rs61734214

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001292063.2(OTOG):​c.2512G>C​(p.Gly838Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00159 in 1,550,570 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0083 ( 22 hom., cov: 33)
Exomes 𝑓: 0.00085 ( 13 hom. )

Consequence

OTOG
NM_001292063.2 missense

Scores

6
8
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1B:5

Conservation

PhyloP100: 7.38

Publications

2 publications found
Variant links:
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
OTOG Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 18B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065345466).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00834 (1270/152278) while in subpopulation AFR AF = 0.0297 (1234/41536). AF 95% confidence interval is 0.0283. There are 22 homozygotes in GnomAd4. There are 589 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGNM_001292063.2 linkc.2512G>C p.Gly838Arg missense_variant Exon 21 of 56 ENST00000399397.6 NP_001278992.1
OTOGNM_001277269.2 linkc.2548G>C p.Gly850Arg missense_variant Exon 20 of 55 NP_001264198.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGENST00000399397.6 linkc.2512G>C p.Gly838Arg missense_variant Exon 21 of 56 5 NM_001292063.2 ENSP00000382329.2
OTOGENST00000399391.7 linkc.2548G>C p.Gly850Arg missense_variant Exon 20 of 55 5 ENSP00000382323.2

Frequencies

GnomAD3 genomes
AF:
0.00831
AC:
1265
AN:
152160
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0297
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00624
GnomAD2 exomes
AF:
0.00158
AC:
236
AN:
149554
AF XY:
0.00127
show subpopulations
Gnomad AFR exome
AF:
0.0306
Gnomad AMR exome
AF:
0.000936
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000181
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000850
AC:
1189
AN:
1398292
Hom.:
13
Cov.:
31
AF XY:
0.000761
AC XY:
525
AN XY:
689670
show subpopulations
African (AFR)
AF:
0.0321
AC:
1014
AN:
31596
American (AMR)
AF:
0.000896
AC:
32
AN:
35704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.000126
AC:
10
AN:
79234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48216
Middle Eastern (MID)
AF:
0.00105
AC:
6
AN:
5698
European-Non Finnish (NFE)
AF:
0.0000185
AC:
20
AN:
1078908
Other (OTH)
AF:
0.00184
AC:
107
AN:
58016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00834
AC:
1270
AN:
152278
Hom.:
22
Cov.:
33
AF XY:
0.00791
AC XY:
589
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0297
AC:
1234
AN:
41536
American (AMR)
AF:
0.00137
AC:
21
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68036
Other (OTH)
AF:
0.00618
AC:
13
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
63
126
189
252
315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00266
Hom.:
5
Bravo
AF:
0.00934
ExAC
AF:
0.00187
AC:
41
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Jun 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 22, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meniere disease Pathogenic:1
Feb 03, 2025
Meniere Disease Neuroscience Research Program, Faculty of Medicine and Health, Kolling Institute, The University of Sydney
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

The NM_001292063.2:c.2512G>C is a rare missense variant in the OTOG gene that was found in a Brazilian patient with Menière's Disease carrying two more rare missense variants in the same gene (M_001292063.2:c.3683C>T and NM_001292063.2:c.3350C>T). This variant has an amino acid change at p.G838R (p.G850R). In silico analysis using pathogenicity prediction algorithms such as the CADD score (27.6), and PolyPhen2 score (1.000), as well as ACMG guidelines for variant interpretation (PS4, PM2, PP3, PP2, BP1), have deemed the variant as "Likely Pathogenic. In silico Protein stability predictions such as DynaMut2 (-0.44kcal/mol) and MuPro (-0.76kcal/mol) have shown it to destabilize the protein. DynaMut2 also predicted a strong destabilization for the protein with the three variants together (-1.9kcal/mol), mimicking the proband's protein. However, experimental evidence is lacking. For the reasons above we have classified this variant as "Likely Pathogenic". -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly850Arg in exon 20 of OTOG: This variant is not expected to have clinical sign ificance because it has been identified in 6.7% (13/194) of Luhya (Kenyan) chrom osomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm. nih.gov/projects/SNP; dbSNP rs61734214). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Uncertain
0.10
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.65
D;.
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
D;D
MetaRNN
Benign
0.0065
T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Pathogenic
3.5
M;.
PhyloP100
7.4
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-7.2
D;.
REVEL
Uncertain
0.46
Sift
Pathogenic
0.0
D;.
Sift4G
Pathogenic
0.0
D;D
Vest4
0.81
MutPred
0.52
Gain of catalytic residue at G850 (P = 0.0558);.;
MVP
0.56
ClinPred
0.087
T
GERP RS
5.2
Varity_R
0.84
gMVP
0.81
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61734214; hg19: chr11-17598128; COSMIC: COSV99063478; COSMIC: COSV99063478; API